{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:39:43Z","timestamp":1792445983273,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Perinatol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1038\/s41372-026-02578-0","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T08:36:51Z","timestamp":1770280611000},"page":"1922-1928","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Variable clinical and hemodynamic effect of sildenafil in extreme premature infants with bronchopulmonary dysplasia-associated pulmonary hypertension"],"prefix":"10.1038","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4868-4125","authenticated-orcid":false,"given":"Krishna Revanna","family":"Gopagondanahalli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime Maria","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce","family":"Khoo May Lyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6563-056X","authenticated-orcid":false,"given":"Sreekanthan","family":"Sundararaghavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2600-7529","authenticated-orcid":false,"given":"Arvind","family":"Sehgal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei Di","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boon Siew","family":"Ooi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7471-751X","authenticated-orcid":false,"given":"Mei Chien","family":"Chua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yee Yin","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Yu","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul Haium Abdul","family":"Alim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5337-8750","authenticated-orcid":false,"given":"Victor Samuel","family":"Rajadurai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,5]]},"reference":[{"key":"2578_CR1","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/ppe.12444","volume":"32","author":"S Arjaans","year":"2018","unstructured":"Arjaans S, Zwart EAH, Ploegstra M, Bos AF, Kooi EMW, Hillege HL, et al. Identification of gaps in the current knowledge on pulmonary hypertension in extremely preterm infants: a systematic review and meta-analysis. Paediatr Perinat Epidemiol. 2018;32:258\u201367.","journal-title":"Paediatr Perinat Epidemiol"},{"key":"2578_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2024.1349175","volume":"12","author":"KR Gopagondanahalli","year":"2024","unstructured":"Gopagondanahalli KR, Abdul Haium AA, Vora SJ, Sundararaghavan S, Ng WD, Choo TLJ, et al. Serial tissue Doppler imaging in the evaluation of bronchopulmonary dysplasia-associated pulmonary hypertension among extremely preterm infants: a prospective observational study. Front Pediatr. 2024;12:1349175.","journal-title":"Front Pediatr"},{"key":"2578_CR3","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1542\/peds.2007-0971","volume":"120","author":"E Khemani","year":"2007","unstructured":"Khemani E, McElhinney DB, Rhein L, Andrade O, Lacro RV, Thomas KC, et al. Pulmonary artery hypertension in formerly premature infants with bronchopulmonary dysplasia: clinical features and outcomes in the surfactant era. Pediatrics. 2007;120:1260\u20139.","journal-title":"Pediatrics"},{"key":"2578_CR4","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ppedcard.2016.12.003","volume":"46","author":"GK Revanna","year":"2017","unstructured":"Revanna GK, Kunjunju A, Sehgal A. Bronchopulmonary dysplasia-associated pulmonary hypertension: making the best use of bedside echocardiography. Prog Pediatr Cardiol. 2017;46:39\u201343.","journal-title":"Prog Pediatr Cardiol"},{"key":"2578_CR5","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.jpeds.2018.07.035","volume":"203","author":"JM Lagatta","year":"2018","unstructured":"Lagatta JM, Hysinger EB, Zaniletti I, Wymore EM, Vyas-Read S, Yallapragada S, et al. The impact of pulmonary hypertension in preterm infants with severe bronchopulmonary dysplasia through 1 year. J Pediatr. 2018;203:218\u2013224.e3.","journal-title":"J Pediatr"},{"key":"2578_CR6","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1002\/ppul.22797","volume":"49","author":"MJ del Cerro","year":"2014","unstructured":"del Cerro MJ, Sabat\u00e9 Rot\u00e9s A, Cart\u00f3n A, Deiros L, Bret M, Cordeiro M, et al. Pulmonary hypertension in bronchopulmonary dysplasia: clinical findings, cardiovascular anomalies and outcomes: Pulmonary Hypertension in BPD. Pediatr Pulmonol. 2014;49:49\u201359.","journal-title":"Pediatr Pulmonol"},{"key":"2578_CR7","doi-asserted-by":"publisher","first-page":"1801916","DOI":"10.1183\/13993003.01916-2018","volume":"53","author":"EB Rosenzweig","year":"2019","unstructured":"Rosenzweig EB, Abman SH, Adatia I, Beghetti M, Bonnet D, Haworth S, et al. Paediatric pulmonary arterial hypertension: updates on definition, classification, diagnostics and management. Eur Respir J. 2019;53:1801916.","journal-title":"Eur Respir J"},{"key":"2578_CR8","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1164\/rccm.201710-2016OC","volume":"198","author":"KN Goss","year":"2018","unstructured":"Goss KN, Beshish AG, Barton GP, Haraldsdottir K, Levin TS, Tetri LH, et al. Early pulmonary vascular disease in young adults born preterm. Am J Respir Crit Care Med. 2018;198:1549\u201358.","journal-title":"Am J Respir Crit Care Med"},{"key":"2578_CR9","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.healun.2019.06.022","volume":"38","author":"G Hansmann","year":"2019","unstructured":"Hansmann G, Koestenberger M, Alastalo TP, Apitz C, Austin ED, Bonnet D, et al. 2019 updated consensus statement on the diagnosis and treatment of pediatric pulmonary hypertension: The European Pediatric Pulmonary Vascular Disease Network (EPPVDN), endorsed by AEPC, ESPR and ISHLT. J Heart Lung Transplant. 2019;38:879\u2013901.","journal-title":"J Heart Lung Transplant"},{"key":"2578_CR10","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jpeds.2018.09.067","volume":"205","author":"JL Cohen","year":"2019","unstructured":"Cohen JL, Nees SN, Valencia GA, Rosenzweig EB, Krishnan US. Sildenafil use in children with pulmonary hypertension. J Pediatr. 2019;205:29\u201334.e1.","journal-title":"J Pediatr"},{"key":"2578_CR11","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/s41390-020-0993-4","volume":"89","author":"G Hansmann","year":"2021","unstructured":"Hansmann G, Sallmon H, Roehr CC, Kourembanas S, Austin ED, Koestenberger M, et al. Pulmonary hypertension in bronchopulmonary dysplasia. Pediatr Res. 2021;89:446\u201355.","journal-title":"Pediatr Res"},{"key":"2578_CR12","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1007\/s00431-015-2515-7","volume":"174","author":"K Tan","year":"2015","unstructured":"Tan K, Krishnamurthy MB, O\u2019Heney JL, Paul E, Sehgal A. Sildenafil therapy in bronchopulmonary dysplasia-associated pulmonary hypertension: a retrospective study of efficacy and safety. Eur J Pediatr. 2015;174:1109\u201315.","journal-title":"Eur J Pediatr"},{"key":"2578_CR13","doi-asserted-by":"publisher","first-page":"L727","DOI":"10.1152\/ajplung.00409.2004","volume":"288","author":"P Deruelle","year":"2005","unstructured":"Deruelle P, Grover TR, Storme L, Abman SH. Effects of BAY 41-2272, a soluble guanylate cyclase activator, on pulmonary vascular reactivity in the ovine fetus. Am J Physiol Lung Cell Mol Physiol. 2005;288:L727\u2013733.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2578_CR14","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1111\/j.1440-1681.2009.05304.x","volume":"37","author":"XZ Sun","year":"2010","unstructured":"Sun XZ, Li ZF, Liu Y, Fang P, Li MX. Inhibition of cGMP phosphodiesterase 5 suppresses matrix metalloproteinase-2 production in pulmonary artery smooth muscles cells. Clin Exp Pharm Physiol. 2010;37:362\u20137.","journal-title":"Clin Exp Pharm Physiol"},{"key":"2578_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/2045894019837875","volume":"9","author":"M Van Der Graaf","year":"2019","unstructured":"Van Der Graaf M, Rojer LA, Helbing WA, Reiss IKM, Etnel JRG, Bartelds B. Sildenafil for bronchopulmonary dysplasia and pulmonary hypertension: a meta-analysis. Pulm circ. 2019;9:1\u20138.","journal-title":"Pulm circ"},{"key":"2578_CR16","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jpeds.2018.04.005","volume":"199","author":"D Aboudi","year":"2018","unstructured":"Aboudi D, Swaminathan N, Brumberg H, Shi Q, Friedman D, Parvez B, et al. Sildenafil and retinopathy of prematurity in preterm infants with bronchopulmonary dysplasia. J Pediatr. 2018;199:16\u201321.","journal-title":"J Pediatr"},{"key":"2578_CR17","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1161\/CIRCULATIONAHA.110.016667","volume":"125","author":"RJ Barst","year":"2012","unstructured":"Barst RJ, Ivy DD, Gaitan G, Szatmari A, Rudzinski A, Garcia AE, et al. A randomized, double-blind, placebo-controlled, dose-ranging study of oral sildenafil citrate in treatment-naive children with pulmonary arterial hypertension. Circulation. 2012;125:324\u201334.","journal-title":"Circulation"},{"key":"2578_CR18","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1164\/ajrccm.163.7.2011060","volume":"163","author":"AH Jobe","year":"2001","unstructured":"Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001;163:1723\u20139.","journal-title":"Am J Respir Crit Care Med"},{"key":"2578_CR19","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1111\/echo.12738","volume":"32","author":"M Nagiub","year":"2015","unstructured":"Nagiub M, Lee S, Guglani L. Echocardiographic assessment of pulmonary hypertension in infants with bronchopulmonary dysplasia: systematic review of literature and a proposed algorithm for assessment. Echocardiography. 2015;32:819\u201333.","journal-title":"Echocardiography"},{"key":"2578_CR20","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12887-019-1492-9","volume":"19","author":"YH Jung","year":"2019","unstructured":"Jung YH, Jang J, Kim HS, Shin SH, Choi CW, Kim EK, et al. Respiratory severity score as a predictive factor for severe bronchopulmonary dysplasia or death in extremely preterm infants. BMC Pediatr. 2019;19:121.","journal-title":"BMC Pediatr"},{"key":"2578_CR21","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1164\/rccm.200503-510OC","volume":"172","author":"F Ladha","year":"2005","unstructured":"Ladha F, Bonnet S, Eaton F, Hashimoto K, Korbutt G, Th\u00e9baud B. Sildenafil improves alveolar growth and pulmonary hypertension in hyperoxia-induced lung injury. Am J Respir Crit Care Med. 2005;172:750\u20136.","journal-title":"Am J Respir Crit Care Med"},{"key":"2578_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2023.1195623","volume":"11","author":"S Yoshida","year":"2023","unstructured":"Yoshida S, Kreger AM, Gittes GK. Intra-amniotic sildenafil treatment improves lung blood flow and pulmonary hypertension in congenital diaphragmatic hernia rats. Front Bioeng Biotechnol. 2023;11:1195623.","journal-title":"Front Bioeng Biotechnol"},{"key":"2578_CR23","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/jp.2011.131","volume":"32","author":"M Nyp","year":"2012","unstructured":"Nyp M, Sandritter T, Poppinga N, Simon C, Truog WE. Sildenafil citrate, bronchopulmonary dysplasia and disordered pulmonary gas exchange: any benefits?. J Perinatol. 2012;32:64\u20139.","journal-title":"J Perinatol"},{"key":"2578_CR24","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1007\/s00246-015-1154-0","volume":"36","author":"MN Trottier-Boucher","year":"2015","unstructured":"Trottier-Boucher MN, Lapointe A, Malo J, Fournier A, Raboisson MJ, Martin B, et al. Sildenafil for the treatment of pulmonary arterial hypertension in infants with bronchopulmonary dysplasia. Pediatr Cardiol. 2015;36:1255\u201360.","journal-title":"Pediatr Cardiol"},{"key":"2578_CR25","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3109\/14767058.2013.818650","volume":"27","author":"K K\u00f6nig","year":"2014","unstructured":"K\u00f6nig K, Barfield CP, Guy KJ, Drew SM, Andersen CC. The effect of sildenafil on evolving bronchopulmonary dysplasia in extremely preterm infants: a randomised controlled pilot study. J Matern Fetal Neonatal Med. 2014;27:439\u201344.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2578_CR26","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1007\/s40261-019-00834-0","volume":"39","author":"FF Abounahia","year":"2019","unstructured":"Abounahia FF, Abu-Jarir R, Abounahia MF, Al-Badriyeh D, Abushanab D, Abu-Ghalwa M, et al. Prophylactic sildenafil in preterm infants at risk of bronchopulmonary dysplasia: a pilot randomized, double-blinded, placebo-controlled trial. Clin Drug Investig. 2019;39:1093\u2013107.","journal-title":"Clin Drug Investig"},{"key":"2578_CR27","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.3390\/children10081397","volume":"10","author":"K Dillon","year":"2023","unstructured":"Dillon K, Lamba V, Philip RR, Weems MF, Talati AJ. Efficacy of sildenafil in infants with bronchopulmonary dysplasia-associated pulmonary hypertension. Child. 2023;10:1397.","journal-title":"Child"},{"key":"2578_CR28","doi-asserted-by":"publisher","first-page":"270","DOI":"10.3390\/children10020270","volume":"10","author":"K Desai","year":"2023","unstructured":"Desai K, Di Lorenzo M, Zuckerman WA, Emeruwa E, Krishnan US. Safety and efficacy of sildenafil for group 2 pulmonary hypertension in left heart failure. Child. 2023;10:270.","journal-title":"Child"},{"key":"2578_CR29","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1055\/s-0035-1571201","volume":"33","author":"NL Swier","year":"2016","unstructured":"Swier NL, Richards B, Cua CL, Lynch SK, Yin H, Nelin LD, et al. Pulmonary vein stenosis in neonates with severe bronchopulmonary dysplasia. Am J Perinatol. 2016;33:671\u20137.","journal-title":"Am J Perinatol"},{"key":"2578_CR30","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1111\/echo.13488","volume":"34","author":"R Bokiniec","year":"2017","unstructured":"Bokiniec R, W\u0142asienko P, Borszewska-Kornacka M, Szymkiewicz-Dangel J. Evaluation of left ventricular function in preterm infants with bronchopulmonary dysplasia using various echocardiographic techniques. Echocardiography. 2017;34:567\u201376.","journal-title":"Echocardiography"},{"key":"2578_CR31","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1007\/s00246-019-02208-x","volume":"40","author":"K De Waal","year":"2019","unstructured":"De Waal K, Costley N, Phad N, Crendal E. Left ventricular diastolic dysfunction and diastolic heart failure in preterm infants. Pediatr Cardiol. 2019;40:1709\u201315.","journal-title":"Pediatr Cardiol"},{"key":"2578_CR32","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1086\/688641","volume":"6","author":"A Sehgal","year":"2016","unstructured":"Sehgal A, Malikiwi A, Paul E, Tan K, Menahem S. A new look at bronchopulmonary dysplasia: postcapillary pathophysiology and cardiac dysfunction. Pulm Circ. 2016;6:508\u201315.","journal-title":"Pulm Circ"},{"key":"2578_CR33","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1378\/chest.113.3.576","volume":"113","author":"CD Vizza","year":"1998","unstructured":"Vizza CD, Lynch JP, Ochoa LL, Richardson G, Trulock EP. Right and left ventricular dysfunction in patients with severe pulmonary disease. Chest. 1998;113:576\u201383.","journal-title":"Chest"},{"key":"2578_CR34","doi-asserted-by":"crossref","unstructured":"Gopagondanahalli KR, Sundararaghavan S, Tan TH, Yeo KT, Vora SJ, Ng WD, et al. Characterizing the role of left ventricular indices and biventricular interaction in bronchopulmonary dysplasia-associated pulmonary hypertension in extreme prematurity. Neonatology. 2025;122:210\u201321.","DOI":"10.1159\/000542980"},{"key":"2578_CR35","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1161\/CIRCHEARTFAILURE.110.944694","volume":"4","author":"M Guazzi","year":"2011","unstructured":"Guazzi M, Vicenzi M, Arena R, Guazzi MD. PDE5 inhibition with sildenafil improves left ventricular diastolic function, cardiac geometry, and clinical status in patients with stable systolic heart failure: results of a 1-year, prospective, randomized, placebo-controlled study. Circ Heart Fail. 2011;4:8\u201317.","journal-title":"Circ Heart Fail"},{"key":"2578_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s40064-015-1317-8","volume":"4","author":"K Eskesen","year":"2015","unstructured":"Eskesen K, Olsen NT, Dimaano VL, Fritz-Hansen T, Sogaard P, Chakir K, et al. Sildenafil treatment attenuates ventricular remodeling in an experimental model of aortic regurgitation. SpringerPlus. 2015;4:592.","journal-title":"SpringerPlus"},{"key":"2578_CR37","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1002\/ejhf.47","volume":"16","author":"X Wu","year":"2014","unstructured":"Wu X, Yang T, Zhou Q, Li S, Huang L. Additional use of a phosphodiesterase 5 inhibitor in patients with pulmonary hypertension secondary to chronic systolic heart failure: a meta-analysis. Eur J Heart Fail. 2014;16:444\u201353.","journal-title":"Eur J Heart Fail"},{"key":"2578_CR38","doi-asserted-by":"publisher","first-page":"2200879","DOI":"10.1183\/13993003.00879-2022","volume":"61","author":"M Humbert","year":"2023","unstructured":"Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RMF, Brida M, et al. 2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J. 2023;61:2200879.","journal-title":"Eur Respir J"},{"key":"2578_CR39","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s00408-018-0089-7","volume":"196","author":"S Hoette","year":"2018","unstructured":"Hoette S, Creuz\u00e9 N, G\u00fcnther S, Montani D, Savale L, Ja\u00efs X, et al. RV fractional area change and TAPSE as predictors of severe right ventricular dysfunction in pulmonary hypertension: a CMR study. Lung. 2018;196:157\u201364.","journal-title":"Lung"},{"key":"2578_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/2045894018816063","volume":"9","author":"AJ Blanca","year":"2019","unstructured":"Blanca AJ, Duijts L, Van Mastrigt E, Pijnenburg MW, Ten Harkel DD, Helbing WA, et al. Right ventricular function in infants with bronchopulmonary dysplasia and pulmonary hypertension: a pilot study. Pulm Circ. 2019;9:1\u20139.","journal-title":"Pulm Circ"},{"key":"2578_CR41","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1161\/01.CIR.68.1.68","volume":"68","author":"ME King","year":"1983","unstructured":"King ME, Braun H, Goldblatt A, Liberthson R, Weyman AE. Interventricular septal configuration as a predictor of right ventricular systolic hypertension in children: a cross-sectional echocardiographic study. Circulation. 1983;68:68\u201375.","journal-title":"Circulation"},{"key":"2578_CR42","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.116.005336","volume":"10","author":"M Koestenberger","year":"2017","unstructured":"Koestenberger M, Grangl G, Avian A, Gamillscheg A, Grillitsch M, Cvirn G, et al. Normal reference values and z scores of the pulmonary artery acceleration time in children and its importance for the assessment of pulmonary hypertension. Circ Cardiovasc Imaging. 2017;10:e005336.","journal-title":"Circ Cardiovasc Imaging"},{"key":"2578_CR43","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1164\/rccm.200907-0988OC","volume":"181","author":"I Blanco","year":"2010","unstructured":"Blanco I, Gimeno E, Munoz PA, Pizarro S, Gistau C, Rodriguez-Roisin R, et al. Hemodynamic and gas exchange effects of sildenafil in patients with chronic obstructive pulmonary disease and pulmonary hypertension. Am J Respir Crit Care Med. 2010;181:270\u20138.","journal-title":"Am J Respir Crit Care Med"},{"key":"2578_CR44","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1161\/hc2901.093117","volume":"104","author":"L Zhao","year":"2001","unstructured":"Zhao L, Mason NA, Morrell NW, Kojonazarov B, Sadykov A, Maripov A, et al. Sildenafil inhibits hypoxia-induced pulmonary hypertension. Circulation. 2001;104:424\u20138.","journal-title":"Circulation"},{"key":"2578_CR45","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/S0140-6736(96)90011-2","volume":"347","author":"JA Barber\u00e0","year":"1996","unstructured":"Barber\u00e0 JA, Roger N, Roca J, Rovira I, Higenbottam TW, Rodriguez-Roisin R. Worsening of pulmonary gas exchange with nitric oxide inhalation in chronic obstructive pulmonary disease. Lancet. 1996;347:436\u201340.","journal-title":"Lancet"},{"key":"2578_CR46","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.chest.2016.09.001","volume":"151","author":"KJ Dunham-Snary","year":"2017","unstructured":"Dunham-Snary KJ, Wu D, Sykes EA, Thakrar A, Parlow LRG, Mewburn JD, et al. Hypoxic pulmonary vasoconstriction: from molecular mechanisms to medicine. Chest. 2017;151:181\u201392.","journal-title":"Chest"},{"key":"2578_CR47","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jpeds.2022.07.039","volume":"251","author":"S Arjaans","year":"2022","unstructured":"Arjaans S, Fries MWF, Schoots MH, Schilte CFM, Roofthooft MTR, Vrijlandt EJLE, et al. Clinical significance of early pulmonary hypertension in preterm infants. J Pediatr. 2022;251:74\u201381.e3.","journal-title":"J Pediatr"}],"container-title":["Journal of Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41372-026-02578-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41372-026-02578-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41372-026-02578-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:01:36Z","timestamp":1792443696000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41372-026-02578-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,5]]},"references-count":47,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["2578"],"URL":"https:\/\/doi.org\/10.1038\/s41372-026-02578-0","relation":{},"ISSN":["0743-8346","1476-5543"],"issn-type":[{"value":"0743-8346","type":"print"},{"value":"1476-5543","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,5]]},"assertion":[{"value":"5 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"This study was done as a clinical audit for BPD-PH in very low birth weight infants. The centralized institute review board (CIRB) exempts the written informed consent from parents for clinical audits. The clinical and echocardiogram data were collected without patient identifiers.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}]}}